Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor Potential Melastatin 3 Ion Channels in Pathophysiology and Treatment

Front Immunol
13 July 2021
https://pubmed.ncbi.nlm.nih.gov/34326841/

Dr Rajka Milanovic Galbraith, LDN Radio Show 16 Aug 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Rajka shares her Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood. 

Dr Pat Crowley, LDN Radio Show 18 Dec 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Pat Crowley shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Pharmacist Neema Yazdanpanah, LDN Radio Show 07 July 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Neema Yazdanpanah shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr Jill Cottel, LDN Radio Show 30 Nov 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Welcome Jill! How does it feel to be our first guest on the new LDN Radio Show?

Dr Jill Cottel: Hello, Linda. It's very exciting.

Researcher Dr Jarred Younger, LDN Radio Show 08 March 2017 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Jarred Younger shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Linda Elsegood: Today I'm joined by Dr Jackie Silkey, who's from just North of Salt Lake City in Utah. She's a functional medicine practitioner. Thank you for joining us, Jackie. 

Dr Jackie Silkey: Thank you for having me. 

Linda Elsegood: Could you tell us how long have you been prescribing LDN? 

Dr Deanna Windham, LDN Radio Show (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Deanna Windham shares her Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.

Dr David Borenstein, LDN Radio Show 28 Dec 2016 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Linda Elsegood: Today we are joined by Dr. David Bornstein.  Thank you for joining us, David. 

Dr David Borenstein: Thank you for having me.